Neuroendocrine Expert Talks

Ipsen
  • 0.0 (0)
  • MEDICINE
Neuroendocrine Expert Talks Podcast

Leaders in the field of neuroendocrine tumors offer insights in this moderated series. The healthcare professionals in this podcast are paid consultants for Ipsen. Each episode features insights on diagnosis, treatment for certain types of NETs, and more. This content is intended for US healthcare providers only. Find out more about a treatment option at TreatingNETs.com. This website uses cookies, which may be considered personal information, to track the number and frequency of podcasts accessed, which may be used for site functionality, performance, and content updates. Please see Ipsen’s Privacy Policy at https://www.ipsen.com/us/privacy-policy/ and Terms of Use at https://www.ipsen.com/us/terms-of-use/.

Episodes

  1. 19/02/2020

    A Multidisciplinary Approach to NETs

    Dr. Robert Ramirez, a member of the American Society of Clinical Oncology (ASCO), and NET nurse navigator Pam Ryan discuss the importance of the multidisciplinary team, building trust, and creating positive treatment experiences for patients with gastrointestinal and pancreatic NETs (GEP-NETs). (c) 2020 Ipsen Biopharmaceuticals, Inc. January 2020 SMD-US-003644

    19 min

  2. 04/06/2019

    Patient With Carcinoid Syndrome

    Dr. Daneng Li, co-director of the neuroendocrine tumor program at City of Hope National Medical Center, offers his expertise and insight on diagnosis, treatment, and dietary practices for a patient with carcinoid syndrome. Patient on this episode is an actor, and represents a hypothetical case. Dr. Li is a paid consultant for Ipsen. ©2019 Ipsen Biopharmaceuticals, Inc. May 2019. SMD-US-002859

    25 min

  3. 04/06/2019

    Patient With Midgut NET

    Dr. Jonathan Strosberg, associate professor at Moffitt Cancer Center, discusses a hypothetical patient with symptomatic carcinoid midgut NET. Dr. Strosberg provides his specific insights on practice considerations for patients having disease progression. Patient on this episode is an actor, and represents a hypothetical case. Dr. Strosberg is a paid consultant for Ipsen. ©2019 Ipsen Biopharmaceuticals, Inc. May 2019. SMD-US-002964

    12 min

  4. 10/04/2019

    Patient with Pancreatic NET

    Dr. Andrew Hendifar, medical oncology lead for the Gastrointestinal Disease Research Group at Cedars-Sinai Medical Center, discusses a hypothetical patient with nonfunctional pancreatic NET. Dr. Hendifar provides practice pointers on disease presentation, tumor characteristics, diagnosis, and a 1st-line treatment option. Patient perspectives on this episode are voiced by actors, and represent hypothetical cases. Dr. Hendifar is a paid consultant for Ipsen. © 2020 Ipsen Biopharmaceuticals, Inc. April 2020. SMD-US-003939

    13 min
  • 4 Episodes

About

Leaders in the field of neuroendocrine tumors offer insights in this moderated series. The healthcare professionals in this podcast are paid consultants for Ipsen. Each episode features insights on diagnosis, treatment for certain types of NETs, and more. This content is intended for US healthcare providers only. Find out more about a treatment option at TreatingNETs.com. This website uses cookies, which may be considered personal information, to track the number and frequency of podcasts accessed, which may be used for site functionality, performance, and content updates. Please see Ipsen’s Privacy Policy at https://www.ipsen.com/us/privacy-policy/ and Terms of Use at https://www.ipsen.com/us/terms-of-use/.

Information

  • Creator
    Ipsen
  • Years Active
    2019 - 2020
  • Episodes
    4
  • Rating
    Clean
  • Copyright
    © 2020 Ipsen Biopharmaceuticals, Inc. February 2020 NON-US-001402
  • Show Website
    Neuroendocrine Expert Talks

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada